151 related articles for article (PubMed ID: 24798973)
1. Inhibition of macrophage polarization prohibits growth of human osteosarcoma.
Xiao Q; Zhang X; Wu Y; Yang Y
Tumour Biol; 2014 Aug; 35(8):7611-6. PubMed ID: 24798973
[TBL] [Abstract][Full Text] [Related]
2. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
3. All-Trans Retinoic Acid Prevents Osteosarcoma Metastasis by Inhibiting M2 Polarization of Tumor-Associated Macrophages.
Zhou Q; Xian M; Xiang S; Xiang D; Shao X; Wang J; Cao J; Yang X; Yang B; Ying M; He Q
Cancer Immunol Res; 2017 Jul; 5(7):547-559. PubMed ID: 28515123
[TBL] [Abstract][Full Text] [Related]
4. Macrophages inhibit human osteosarcoma cell growth after activation with the bacterial cell wall derivative liposomal muramyl tripeptide in combination with interferon-γ.
Pahl JH; Kwappenberg KM; Varypataki EM; Santos SJ; Kuijjer ML; Mohamed S; Wijnen JT; van Tol MJ; Cleton-Jansen AM; Egeler RM; Jiskoot W; Lankester AC; Schilham MW
J Exp Clin Cancer Res; 2014 Mar; 33(1):27. PubMed ID: 24612598
[TBL] [Abstract][Full Text] [Related]
5. Tumor-derived Exosomes Induced M2 Macrophage Polarization and Promoted the Metastasis of Osteosarcoma Cells Through Tim-3.
Cheng Z; Wang L; Wu C; Huang L; Ruan Y; Xue W
Arch Med Res; 2021 Feb; 52(2):200-210. PubMed ID: 33162186
[TBL] [Abstract][Full Text] [Related]
6. Tumor-derived microparticles promoted M2-like macrophages polarization to stimulate osteosarcoma progression.
Li C; Xiang F; Gong Y; Fu Y; Chen G; Wang Z; Li Z; Wei D
Int J Biochem Cell Biol; 2024 Jan; 166():106494. PubMed ID: 37956954
[TBL] [Abstract][Full Text] [Related]
7. Antitumor and antimetastatic actions of dihydroxycoumarins (esculetin or fraxetin) through the inhibition of M2 macrophage differentiation in tumor-associated macrophages and/or G1 arrest in tumor cells.
Kimura Y; Sumiyoshi M
Eur J Pharmacol; 2015 Jan; 746():115-25. PubMed ID: 25445053
[TBL] [Abstract][Full Text] [Related]
8. Macrophage Repolarization as a Therapeutic Strategy for Osteosarcoma.
Anand N; Peh KH; Kolesar JM
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769180
[TBL] [Abstract][Full Text] [Related]
9. Circular RNA
Li H; Lan M; Liao X; Tang Z; Yang C
Technol Cancer Res Treat; 2020; 19():1533033819898728. PubMed ID: 31960764
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma.
Dumars C; Ngyuen JM; Gaultier A; Lanel R; Corradini N; Gouin F; Heymann D; Heymann MF
Oncotarget; 2016 Nov; 7(48):78343-78354. PubMed ID: 27823976
[TBL] [Abstract][Full Text] [Related]
11. EGFR is required for FOS-dependent bone tumor development via RSK2/CREB signaling.
Linder M; Glitzner E; Srivatsa S; Bakiri L; Matsuoka K; Shahrouzi P; Dumanic M; Novoszel P; Mohr T; Langer O; Wanek T; Mitterhauser M; Wagner EF; Sibilia M
EMBO Mol Med; 2018 Nov; 10(11):. PubMed ID: 30361264
[TBL] [Abstract][Full Text] [Related]
12. LncRNA LOC100129620 promotes osteosarcoma progression through regulating CDK6 expression, tumor angiogenesis, and macrophage polarization.
Chen Y; Tang G; Qian H; Chen J; Cheng B; Zhou C; Shen Y
Aging (Albany NY); 2021 May; 13(10):14258-14276. PubMed ID: 34015762
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of M2-like macrophages by all-trans retinoic acid prevents cancer initiation and stemness in osteosarcoma cells.
Shao XJ; Xiang SF; Chen YQ; Zhang N; Cao J; Zhu H; Yang B; Zhou Q; Ying MD; He QJ
Acta Pharmacol Sin; 2019 Oct; 40(10):1343-1350. PubMed ID: 31296953
[TBL] [Abstract][Full Text] [Related]
14. Sodium cantharidate targets STAT3 and abrogates EGFR inhibitor resistance in osteosarcoma.
Ji XL; He M
Aging (Albany NY); 2019 Aug; 11(15):5848-5863. PubMed ID: 31422383
[TBL] [Abstract][Full Text] [Related]
15. The TGFβ-miR-499a-SHKBP1 pathway induces resistance to EGFR inhibitors in osteosarcoma cancer stem cell-like cells.
Wang T; Wang D; Zhang L; Yang P; Wang J; Liu Q; Yan F; Lin F
J Exp Clin Cancer Res; 2019 May; 38(1):226. PubMed ID: 31138318
[TBL] [Abstract][Full Text] [Related]
16. MAT2B promotes proliferation and inhibits apoptosis in osteosarcoma by targeting epidermal growth factor receptor and proliferating cell nuclear antigen.
Yuan Y; Wang Y; Liu Z; Sun Y; Yao Y; Yu W; Shen Z
Int J Oncol; 2019 Jun; 54(6):2019-2029. PubMed ID: 30942439
[TBL] [Abstract][Full Text] [Related]
17. TIPE1 suppresses osteosarcoma tumor growth by regulating macrophage infiltration.
Chen P; Zhou J; Li J; Zhang Q; Zuo Q
Clin Transl Oncol; 2019 Mar; 21(3):334-341. PubMed ID: 30062520
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid receptor-2 agonist inhibits macrophage induced EMT in non-small cell lung cancer by downregulation of EGFR pathway.
Ravi J; Elbaz M; Wani NA; Nasser MW; Ganju RK
Mol Carcinog; 2016 Dec; 55(12):2063-2076. PubMed ID: 26741322
[TBL] [Abstract][Full Text] [Related]
19. Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agents.
Buddingh EP; Kuijjer ML; Duim RA; Bürger H; Agelopoulos K; Myklebost O; Serra M; Mertens F; Hogendoorn PC; Lankester AC; Cleton-Jansen AM
Clin Cancer Res; 2011 Apr; 17(8):2110-9. PubMed ID: 21372215
[TBL] [Abstract][Full Text] [Related]
20. Blue LED causes autophagic cell death in human osteosarcoma by increasing ROS generation and dephosphorylating EGFR.
He M; Yan G; Wang Y; Gong R; Lei H; Yu S; He X; Li G; Du W; Ma T; Gao M; Yu M; Liu S; Xu Z; Idiiatullina E; Zagidullin N; Pavlov V; Cai B; Yuan Y; Yang L
J Cell Mol Med; 2021 Jun; 25(11):4962-4973. PubMed ID: 33960631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
